Publication | Closed Access

Kelatorphan, a potent enkephalinases inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administration

Psychoactive DrugPsychiatryBehavioral NeuroscienceAddictionNeurophysiologyMedicinePsychopharmacologyNeuropharmacologyPharmacotherapyNeuroscienceNervous SystemPharmacologySocial SciencesOpioid Use DisorderModulate Self-stimulation Behaviour